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BACKGROUND
The relationship between wealth and health outcomes is one of the

RESULT
S

most important topics in the field of health economics. If it could be

GDP on health outcomes, with the results being insignificant and

According to this model, there is little to no causal effect of a state’s

demonstrably shown that wealthier people live much healthier lives,

inconclusive in almost every measurable way. In Fig. 3, the z-statistic

then economic growth would certainly need to have a bigger role in

of 0.99 and the corresponding p-value show that the coefficient of the

health care reform. However, the literature on this topic is intensely

GDP variable is not statistically significant at the 5% or even 10%

mixed, and it has proven to be one of the most hotly debated topics

level. In addition, the 95% confidence interval shows that it is uncertain

the field, with some, such as Arthur van Soest, concluding that the

whether the effect of GDP on health outcomes is positive or negative –

“health-wealth gradient” is not an important factor to consider in

such an uncertain result means that this model shows no evidence of

health care reform, but others, such as Hannes Schwandt,

a causal link between a state’s GDP and its health outcomes.

concluding that wealth is an important factor to consider.

DAT
A

METHODS

CONCLUSIONS

Data was assembled from the following sources:

The goal of this model is to estimate the effect of real GDP on health

These findings support the conclusion, as argued by Arthur van Soest

• America’s Health Rankings, a product of UHF. This rating system

outcomes. With observations from the years 2003 and 2013, this

and others, that the “health-wealth gradient,” while an interesting idea,

measures health outcomes such as cancer deaths, diabetes and

dataset made a great candidate for instrumental variable analysis.

doesn’t adequately describe how health outcomes transpire in the

infant mortality to assign each state an index value of health

Thus, the main methods used in model-building were instrumental

United States. Factors besides individual wealth must be prioritized in

outcomes from -1 to +1.

variable analysis and two-stage least squares regression.

the modeling of health outcomes.

• BEA estimates of real GDP per capita in the years 2003 and 2013.
Both years’ estimates use a base year of 1990.
• Region-based effects were controlled using regional groups as
defined by the BEA.

In the first stage, I use GDP in the year 2003 as an instrument upon
GDP in the year 2013. GDP in 2003 meets the requirements of a
strong instrument: it is highly correlated with GDP in 2013, but
uncorrelated with a state’s health index in 2013 (see Fig. 2). Using an
instrument gives a much more accurate estimate, reducing the

Some of the more interesting EDA results are shown in Fig. 1. In

possibility of omitted variable bias in the model.

terms of GDP, there is a large gap between the top seven states and

In the second stage, I use the instrumented variable to estimate the

the rest. The linear prediction shows an apparent positive relationship

effect of GDP upon health outcomes, producing the regression output

between wealth and health outcomes, but this is before any real

seen in Fig. 3.

model-building takes place.

IMPROVEMENTS /
FURTHER RESEARCH
• Continuing to develop and improve the data set will make
for more robust results.
• Longitudinal analysis could be used as an alternative to
instrumental variable regression, but this would require a
change in the way observations are grouped.
• An exploration into the policy implications of these
findings will greatly enhance the research.

